The active ingredient in compounded semaglutide is the same molecule that Novo Nordisk sells as Wegovy (FDA-approved for chronic weight management) and Ozempic (FDA-approved for type 2 diabetes, prescribed off-label for weight loss)
Although DPP4i has shown many anti-inflammatory effects in diabetes complications and other disease, this effect has not been shown in clinical trials
Avoid: If your pen has been frozen, exposed to incorrect temperatures, or is past its expiry date, it should not be used
Mechanistic investigations using pathway inhibitors or transgenic models are essential to elucidate the causal link between SGLT2 inhibition and hepatic signaling pathways
Even though more people in these communities have diabetes, accessing health care is a serious challenge due to high costs, insurance coverage gaps and geographic disparities, particularly in rural and diverse communities
C.KrugD.GuptaA.et al (2003)